CVS Health (CVS) Tops Q4 EPS by 9c, FY EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/7/2026
- Rivian Automotive (RIVN) files for 75M share offering
- Rivian offers Q2 2026 revenue outlook, cash position grows
- Nokia OYJ (NOKIA:FH) (NOK) PT Raised to EUR14 at Kepler Cheuvreux
- Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
- Coursera plans layoffs after Udemy merger, estimates $8M-$11M in costs
CVS Health (CVS) PT Lowered to $68 at Baird
February 21, 2019 8:35 AM ESTBaird analyst Eric Coldwell lowered the price target on CVS Health (NYSE: CVS) to $68.00 (from $86.00) while maintaining a Neutral rating. Mid-$7 EPS in 2020 looks like a best-case scenario. Derivative reads scattered throughout CVS update, most of them unfavorable for peers/vendors.
CVS is... More
